Fluctuating blood glucose levels in an elderly diabetic patient.

摘要

I read with great interest the letter by Bobba et al, entitled "Hyperglycemia in an elderly diabetic patient: Drug-drug or drug-disease interaction?" in which an elderly patient experienced loss of glycemic control potentially due to the use of gatifloxacin, a newer fiuoroquinolone antibacterial agent. The case report does emphasize the need for providers to consider potential drug-related causes or interactions when evaluating a patient with symptomatic alterations in glycemic control. A variety of pharmacologic agents have been linked to the development of abnormal glucose metabolism, diabetes mellitus, hypo-glycemia and hyperglycemia.